Cargando…

Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review

INTRODUCTION: We conducted a systematic literature review to assess the utility of liver function assessments for predicting disease prognosis and response to systemic anticancer therapy in patients with advanced hepatocellular carcinoma (aHCC). METHODS: This was a PRISMA-standard review and was reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Arndt, Kelley, Robin K., Johnson, Philip, Merle, Philippe, Yau, Thomas, Kudo, Masatoshi, Meyer, Tim, Rimassa, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561324/
https://www.ncbi.nlm.nih.gov/pubmed/37817754
http://dx.doi.org/10.1159/000529173
_version_ 1785117898464821248
author Vogel, Arndt
Kelley, Robin K.
Johnson, Philip
Merle, Philippe
Yau, Thomas
Kudo, Masatoshi
Meyer, Tim
Rimassa, Lorenza
author_facet Vogel, Arndt
Kelley, Robin K.
Johnson, Philip
Merle, Philippe
Yau, Thomas
Kudo, Masatoshi
Meyer, Tim
Rimassa, Lorenza
author_sort Vogel, Arndt
collection PubMed
description INTRODUCTION: We conducted a systematic literature review to assess the utility of liver function assessments for predicting disease prognosis and response to systemic anticancer therapy in patients with advanced hepatocellular carcinoma (aHCC). METHODS: This was a PRISMA-standard review and was registered with PROSPERO (CRD42021244588). MEDLINE and Embase were systematically searched (March 24, 2021) to identify publications reporting the efficacy and/or safety of systemic anticancer therapy (vs. any/no comparator) in liver-function-defined subgroups in phase 2 or 3 aHCC trials. Screening was completed by a single reviewer, with uncertainties resolved by a second reviewer and/or the authors. English-language full-text articles and congress abstracts were eligible for inclusion. Included publications were described and assessed for risk of bias using the GRADE methodology. RESULTS: Twenty (of 2,579) screened publications were eligible; seven categorized liver function using the albumin-bilirubin system, nine using the Child-Pugh system, four using both. GRADE assessment classified ten, nine, and one publication(s) as reporting moderate-quality, low-quality, and very-low-quality evidence, respectively. Analyses of cross-trial trends of within-exposure arm analyses (active and control) reported a positive relationship between baseline liver function and overall survival and progression-free survival, supporting liver function as a prognostic marker in aHCC. There were also signals for a modest relationship between more preserved baseline liver function and extent of systemic treatment benefit, and with more preserved liver function and lower incidence of safety events. CONCLUSION: This review supports liver function as a prognostic variable in aHCC and highlights the value of a priori stratification of patients by baseline liver function in aHCC trials. The predictive value of liver function warrants further study. Findings were limited by the quality of available data.
format Online
Article
Text
id pubmed-10561324
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-105613242023-10-10 Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review Vogel, Arndt Kelley, Robin K. Johnson, Philip Merle, Philippe Yau, Thomas Kudo, Masatoshi Meyer, Tim Rimassa, Lorenza Liver Cancer Research Article INTRODUCTION: We conducted a systematic literature review to assess the utility of liver function assessments for predicting disease prognosis and response to systemic anticancer therapy in patients with advanced hepatocellular carcinoma (aHCC). METHODS: This was a PRISMA-standard review and was registered with PROSPERO (CRD42021244588). MEDLINE and Embase were systematically searched (March 24, 2021) to identify publications reporting the efficacy and/or safety of systemic anticancer therapy (vs. any/no comparator) in liver-function-defined subgroups in phase 2 or 3 aHCC trials. Screening was completed by a single reviewer, with uncertainties resolved by a second reviewer and/or the authors. English-language full-text articles and congress abstracts were eligible for inclusion. Included publications were described and assessed for risk of bias using the GRADE methodology. RESULTS: Twenty (of 2,579) screened publications were eligible; seven categorized liver function using the albumin-bilirubin system, nine using the Child-Pugh system, four using both. GRADE assessment classified ten, nine, and one publication(s) as reporting moderate-quality, low-quality, and very-low-quality evidence, respectively. Analyses of cross-trial trends of within-exposure arm analyses (active and control) reported a positive relationship between baseline liver function and overall survival and progression-free survival, supporting liver function as a prognostic marker in aHCC. There were also signals for a modest relationship between more preserved baseline liver function and extent of systemic treatment benefit, and with more preserved liver function and lower incidence of safety events. CONCLUSION: This review supports liver function as a prognostic variable in aHCC and highlights the value of a priori stratification of patients by baseline liver function in aHCC trials. The predictive value of liver function warrants further study. Findings were limited by the quality of available data. S. Karger AG 2023-01-17 /pmc/articles/PMC10561324/ /pubmed/37817754 http://dx.doi.org/10.1159/000529173 Text en Copyright © 2023 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher.
spellingShingle Research Article
Vogel, Arndt
Kelley, Robin K.
Johnson, Philip
Merle, Philippe
Yau, Thomas
Kudo, Masatoshi
Meyer, Tim
Rimassa, Lorenza
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
title Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
title_full Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
title_fullStr Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
title_full_unstemmed Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
title_short Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
title_sort predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561324/
https://www.ncbi.nlm.nih.gov/pubmed/37817754
http://dx.doi.org/10.1159/000529173
work_keys_str_mv AT vogelarndt predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT kelleyrobink predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT johnsonphilip predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT merlephilippe predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT yauthomas predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT kudomasatoshi predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT meyertim predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview
AT rimassalorenza predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview